Cancer Cell-Intrinsic PD-1 and immune-microenvironment boost tumor growth upon immune-checkpoint inhibitors in NSCLC
Ente Finanziatore: MFAG AIRC
Principal Investigator: Dott. Lo Russo Giuseppe
Data di inizio:
Data di fine:
Struttura Principale: Oncologia Medica 1 - Unità Oncologia Medica Melanomi
Study on tumor- or tumor microenvironment-related mechanisms underlying the phenomenon of hyperprogressive disease in patients treated with immunotherapeutic agents.
Principal Investigator Dr. Lo Russo Giuseppe
Struttura Principale: Oncologia Medica 1 - Unità Oncologia Medica Melanomi
Area Clinica, Struttura Semplice
Thoracic Oncology Unit
Clinical Area, Simple Structure
Molecular Immunology
Research Area, Complex Structure
Last update: 26/05/2025